Skip to content
value.today

BridgePoint Medical, Inc.

Formerly Prospex Medical Inc

Total raised
$16 M
3 rounds on record
Latest round
$9 M
Dec 2010
First round on record
Aug 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of BridgePoint Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2010$9 MNo. 3$2 to $10 million

BridgePoint Medical, Inc.: Raise no. 3, Dec 2010

Investors in this round

7 investors had bought by the notice of Dec 17, 2010: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chad Kugler · Executive Officer, Director
  • Craig Schlawin · Executive Officer
  • John Schultz · Executive Officer
  • Matthew Olson · Executive Officer
  • Andrew Firlik · Director
  • Brian Chee · Director
  • John Nehra · Director
  • Michael Berman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds from the offering will be used for working capital and general corporate purposes. The company's executive officers will receive compensation in their capacity as executive officers only.”

Signed by Chad Kugler, President and General Manager. Source: SEC Form D, newest notice filed Dec 17, 2010. Read the notice at the SEC.

equitySEC
Nov 2010$1 MNo. 2Under $2 million

BridgePoint Medical, Inc.: Raise no. 2, Nov 2010

Investors in this round

6 investors had bought by the notice of Nov 16, 2010: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 505: the former limited-offering exemption (withdrawn in 2017)
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chad Kugler · Executive Officer, Director
  • Michael Berman · Executive Officer, Director
  • Andrew Firlik · Director
  • Brian Chee · Director
  • John Nehra · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds from the offering will be used for working capital and general corporate purposes. Mr. Kugler will receive compensation in his capacity as President and General Manager of the company only.”

Signed by Chad Kugler, President and General Manager. Source: SEC Form D, newest notice filed Nov 16, 2010. Read the notice at the SEC.

debt, optionsSEC
Aug 2009$6 MNo. 1$2 to $10 million

BridgePoint Medical, Inc.: Raise no. 1, Aug 2009

Investors in this round

6 investors had bought by the notice of Aug 17, 2009: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chad Kugler · Executive Officer, Director
  • Michael Berman · Executive Officer, Director
  • Andrew Firlik · Director
  • Brian Chee · Director
  • John Nehra · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds from the offering will be used for working capital and general corporate purposes. Mr. Kugler will receive compensation in his capacity as President and General Manager of the company only.”

Signed by Chad Kugler, President and General Manager. Source: SEC Form D, newest notice filed Aug 17, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • BridgePoint Medical, Inc. had no revenue when it filed its newest notice of a funding round (Dec 2010).

    SEC Form D (revenue range) · Dec 2010

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2010

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of BridgePoint Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by BridgePoint Medical, Inc.
NameRoleNamed in
Chad KuglerExecutive officerDec 2010
Craig SchlawinExecutive officerDec 2010
John SchultzExecutive officerDec 2010
Matthew OlsonExecutive officerDec 2010
Michael BermanExecutive officerNov 2010
Andrew FirlikDirectorDec 2010
Brian CheeDirectorDec 2010
Chad KuglerDirectorDec 2010
John NehraDirectorDec 2010
Michael BermanDirectorDec 2010